Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Post

Showing results (111-120 of 136) with videos related to

Pageof 14
Sort By:
Therapeutics and Clinical Risk Management|October 22, 2019
Clinical Pathways For Pancreatic Surgery: Are They A Suitable Instrument For Process Standardization To Improve Process And Outcome Quality Of Patients Undergoing Distal And Total Pancreatectomy? - A Retrospective Cohort StudyPatrick Téoule, Laura Römling, Matthias Schwarzbach, et al.
Transplantation|March 30, 2002
Modulation of IFN-gamma-induced immunogenicity by phosphatidylethanolamine-linked hyaluronic acidBenito A Yard, Saul Yedgar, Martin Scheele, et al.
Asian Journal of Surgery|November 17, 2019
Influence of Clinical pathways on treatment and outcome quality for patients undergoing pancreatoduodenectomy? A retrospective cohort studyPatrick Téoule, Britta Kunz, Matthias Schwarzbach, et al.
Langenbeck'S Archives of Surgery|February 1, 2012
Complications after end-to-end vs. side-to-side anastomosis in ileocecal Crohn's disease--early postoperative results from a randomized controlled multi-center trial (ISRCTN-45665492)Urte Zurbuchen, Anton J Kroesen, Philipp Knebel, et al.
International Journal of Radiation Oncology, Biology, Physics|October 16, 2010
KRAS and BRAF mutations and PTEN expression do not predict efficacy of cetuximab-based chemoradiotherapy in locally advanced rectal cancerPhilipp Erben, Philipp Ströbel, Karoline Horisberger, et al.
BMC Cancer|August 23, 2011
Expression of Transketolase like gene 1 (TKTL1) predicts disease-free survival in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapyJuliana Schwaab, Karoline Horisberger, Philipp Ströbel, et al.
International Journal of Radiation Oncology, Biology, Physics|September 19, 2006
Phase I trial of cetuximab in combination with capecitabine, weekly irinotecan, and radiotherapy as neoadjuvant therapy for rectal cancerRalf-Dieter Hofheinz, Karoline Horisberger, Christoph Woernle, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|August 5, 2011
Letter from the ESCP ExecutiveFreddy Penninckx, Zoran Krivokapic, Ronan O'Connell, et al.
Plos One|May 27, 2015
Amplicon sequencing of colorectal cancer: variant calling in frozen and formalin-fixed samplesJohannes Betge, Grainne Kerr, Thilo Miersch, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 8, 2010
Induction chemotherapy before chemoradiotherapy and surgery for locally advanced rectal cancer : is it time for a randomized phase III trial?Claus Rödel, Dirk Arnold, Heinz Becker, et al.
Pageof 14

Showing results (111-120 of 136) with videos related to

Sort By:
Pageof 14
Therapeutics and Clinical Risk Management|October 22, 2019
Clinical Pathways For Pancreatic Surgery: Are They A Suitable Instrument For Process Standardization To Improve Process And Outcome Quality Of Patients Undergoing Distal And Total Pancreatectomy? - A Retrospective Cohort StudyPatrick Téoule, Laura Römling, Matthias Schwarzbach, et al.
Transplantation|March 30, 2002
Modulation of IFN-gamma-induced immunogenicity by phosphatidylethanolamine-linked hyaluronic acidBenito A Yard, Saul Yedgar, Martin Scheele, et al.
Asian Journal of Surgery|November 17, 2019
Influence of Clinical pathways on treatment and outcome quality for patients undergoing pancreatoduodenectomy? A retrospective cohort studyPatrick Téoule, Britta Kunz, Matthias Schwarzbach, et al.
Langenbeck'S Archives of Surgery|February 1, 2012
Complications after end-to-end vs. side-to-side anastomosis in ileocecal Crohn's disease--early postoperative results from a randomized controlled multi-center trial (ISRCTN-45665492)Urte Zurbuchen, Anton J Kroesen, Philipp Knebel, et al.
International Journal of Radiation Oncology, Biology, Physics|October 16, 2010
KRAS and BRAF mutations and PTEN expression do not predict efficacy of cetuximab-based chemoradiotherapy in locally advanced rectal cancerPhilipp Erben, Philipp Ströbel, Karoline Horisberger, et al.
BMC Cancer|August 23, 2011
Expression of Transketolase like gene 1 (TKTL1) predicts disease-free survival in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapyJuliana Schwaab, Karoline Horisberger, Philipp Ströbel, et al.
International Journal of Radiation Oncology, Biology, Physics|September 19, 2006
Phase I trial of cetuximab in combination with capecitabine, weekly irinotecan, and radiotherapy as neoadjuvant therapy for rectal cancerRalf-Dieter Hofheinz, Karoline Horisberger, Christoph Woernle, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|August 5, 2011
Letter from the ESCP ExecutiveFreddy Penninckx, Zoran Krivokapic, Ronan O'Connell, et al.
Plos One|May 27, 2015
Amplicon sequencing of colorectal cancer: variant calling in frozen and formalin-fixed samplesJohannes Betge, Grainne Kerr, Thilo Miersch, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 8, 2010
Induction chemotherapy before chemoradiotherapy and surgery for locally advanced rectal cancer : is it time for a randomized phase III trial?Claus Rödel, Dirk Arnold, Heinz Becker, et al.
Pageof 14